Variant report
Variant | esv2421554 |
---|---|
Chromosome Location | chr8:115693718-115728363 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:120719872..120722285-chr8:115706379..115707879,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530170942 | chr8:115693735-115693736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570731784 | chr8:115693778-115693779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528973449 | chr8:115693782-115693783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs28605498 | chr8:115693802-115693803 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs568690566 | chr8:115693809-115693810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539384890 | chr8:115693836-115693837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557597997 | chr8:115693837-115693838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114124622 | chr8:115693840-115693841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140419425 | chr8:115693886-115693887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563385131 | chr8:115693902-115693903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114775713 | chr8:115693904-115693905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540542407 | chr8:115693987-115693988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537950371 | chr8:115693996-115693997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532289313 | chr8:115694000-115694001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs193103945 | chr8:115694043-115694044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556822415 | chr8:115694081-115694082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539209548 | chr8:115694099-115694100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545729874 | chr8:115694137-115694138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151157183 | chr8:115694167-115694168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185086120 | chr8:115694220-115694221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140209493 | chr8:115694351-115694352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375219499 | chr8:115694475-115694476 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35601754 | chr8:115694478-115694479 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565930352 | chr8:115694503-115694504 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529452124 | chr8:115694507-115694508 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34578524 | chr8:115694559-115694560 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34037408 | chr8:115694582-115694583 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72690215 | chr8:115694595-115694596 | Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs7826812 | chr8:115694602-115694603 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs150348157 | chr8:115694619-115694620 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532935013 | chr8:115694646-115694647 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138059984 | chr8:115694650-115694651 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566388465 | chr8:115694696-115694697 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77039852 | chr8:115694709-115694710 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs398068179 | chr8:115694713-115694714 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533836616 | chr8:115694720-115694721 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549405009 | chr8:115694731-115694732 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567531632 | chr8:115694737-115694738 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149531212 | chr8:115694744-115694745 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537183574 | chr8:115694745-115694746 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190068025 | chr8:115694751-115694752 | Weak transcription Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146081556 | chr8:115694845-115694846 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116425114 | chr8:115694859-115694860 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557087737 | chr8:115694860-115694861 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572747728 | chr8:115694869-115694870 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376951039 | chr8:115694876-115694877 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115885523 | chr8:115694885-115694886 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561759190 | chr8:115694952-115694953 | Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7826427 | chr8:115724639-115724640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs567979255 | chr8:115724647-115724648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115693000-115694400 | Enhancers | Dnd41 | blood |
2 | chr8:115693800-115694800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr8:115694400-115695000 | ZNF genes & repeats | Aorta | Aorta |
4 | chr8:115694400-115695000 | ZNF genes & repeats | Dnd41 | blood |
5 | chr8:115694600-115694800 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:115694600-115695000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr8:115694800-115695000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr8:115694800-115695000 | Flanking Bivalent TSS/Enh | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr8:115694800-115695000 | ZNF genes & repeats | Lung | lung |
10 | chr8:115724600-115725800 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr8:115724800-115725200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr8:115724800-115725600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr8:115725000-115726400 | Enhancers | Hela-S3 | cervix |
14 | chr8:115725600-115729600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |